Joshua Boger
Joshua S. Boger (born April 12, 1951) is an organic chemist and the founder of Vertex Pharmaceuticals Incorporated. He is considered a pioneer in the field of structure-based rational drug design. Drugs developed include amprenavir, an HIV protease inhibitor; telaprevir, a protease inhibitor for treatment of hepatitis C; and Kalydeco, for the treatment of cystic fibrosis. In 2003, Vertex was listed as one of forty worldwide Technology Pioneers by the World Economic Forum. As of 2012, Boger became executive chairman of Alkeus Pharmaceuticals.
primaryTopic
Joshua Boger
Joshua S. Boger (born April 12, 1951) is an organic chemist and the founder of Vertex Pharmaceuticals Incorporated. He is considered a pioneer in the field of structure-based rational drug design. Drugs developed include amprenavir, an HIV protease inhibitor; telaprevir, a protease inhibitor for treatment of hepatitis C; and Kalydeco, for the treatment of cystic fibrosis. In 2003, Vertex was listed as one of forty worldwide Technology Pioneers by the World Economic Forum. As of 2012, Boger became executive chairman of Alkeus Pharmaceuticals.
has abstract
Joshua S. Boger (born April 12 ...... man of Alkeus Pharmaceuticals.
@en
academic discipline
alma mater
birth date
1951-04-12
birth place
Link from a Wikipage to an external page
Wikipage page ID
56,323,304
page length (characters) of wiki page
Wikipage revision ID
985,698,500
Link from a Wikipage to another Wikipage
align
right
@en
alma mater
birth date
1951-04-12
birth place
caption
Joshua Boger, 2012
@en
field
Structure-based rational drug design
@en
name
Joshua S. Boger
@en
spouse
Amy Schafer Boger
@en
video
“Joshua Boger '73: Cure Entrepreneur”, Wesleyan University, Apr 6, 2011
@en
wikiPageUsesTemplate
work institutions
subject
comment
Joshua S. Boger (born April 12 ...... man of Alkeus Pharmaceuticals.
@en
label
Joshua Boger
@en
sameAs
wasDerivedFrom
isPrimaryTopicOf
name
Joshua S. Boger
@en